Journal of Psoriasis and Psoriatic Arthritis

The Journal of Psoriasis and Psoriatic Arthritis (JPPA) is a peer-reviewed specialty journal of the National Psoriasis Foundation. It is published for dermatology and rheumatology specialists, and for the psoriatic disease community. The journal, which was launched in February 1995, provides the latest research and practical treatment information about psoriasis, psoriatic arthritis and related comorbidities and conditions in a concise and easy-to-read format.

Professional members of NPF have free access to the journal through SAGE journals

JPPA bases its policies on the guidelines set forth by the International Committee of Medical Journal Editors. Earn AMA PRA Category 1 Credit(s)™ for selected articles.

JPPA is a member of the Committee on Publication Ethics (COPE).

JPPA is included in the ProQuest and Scopus abstracting and indexing databases.

Editor-in-Chief

Bruce Strober, M.D., Ph.D
Yale University
New Haven, Connecticut

Founding Editors

Alice B. Gottlieb, M.D., Ph.D
Icahn School of Medicine at Mount Sinai
New York, New York

John Y. M. Koo, M.D.
University of California San Francisco Medical Center
San Francisco, Californi

Mark Lebwohl, M.D.
Icahn School of Medicine at Mount Sinai
New York, New York

Senior Editors

April Armstrong, M.D., M.P.H.
Keck School of Medicine at USC
Los Angeles, California

Andrew Blauvelt, M.D., M.B.A.
 Oregon Medical Research Center
Portland, Oregon

Joseph Merola, M.D., MMSc
Harvard Medical School
Boston, Massachusetts

Publish in JPPA

Medical professionals are invited to submit articles to be considered for publication.

Benefits to authors include:

  • Rigorous peer review
  • No publication fees
  • Multidisciplinary audience
  • High visibility among NPF community

Manuscripts submitted to JPPA should be of general interest to researchers and medical professionals specializing in psoriatic disease research and patient care. Articles are typically 900-3,000 words long, but longer articles will be considered. There are no fees payable to submit or publish in this journal.

Current Issue Table of Contents

Volume 5 Issue 3 (July 2020)

"Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update"
Nicholas D. Brownstone, M.D., Vidhatha Reddy, B.A., Quinn Thibodeaux, M.D., Stephanie Chan, BS, Bridget Myers, M.D., Tina Bhutani, M.D., John Y. M. Koo, M.D.

"Certolizumab-Induced Paradoxical Psoriatic Alopecia"
María Guillermina Ferraresso, M.D., María Luz Bollea Garlatti, M.D., Lourdes María Perez-Chada, M.D.,

"Anticipated and Perceived Stigma Among Patients With Psoriasis"
Marilyn T. Wan, MBChB, MPH, Rebecca L. Pearl, Ph.D, Zelma C. Chiesa Fuxench, M.D., MSCE, Junko Takeshita, M.D., Ph.D, MSCE, Joel M. Gelfand, M.D., MSCE

"Predictors of Biologic Use and Satisfaction Among Patients With Psoriasis: An Analysis and Geographic Visualization of the 2016 and 2017 National Psoriasis Foundation Annual Surveys"
Clinton W. Enos, M.D., Hadiza Galadima, Ph.D, Arjun D. Saini, M.D., Stacie Bell, Ph.D, Michael Siegel, Ph.D, Abby S. Van Voorhees, M.D.

"An Analysis of the Perception of Psoriasis Symptoms and the Impact on Willingness to Seek Medical Attention"
Jeremy K. Bray, B.A., Steven R. Feldman, M.D., Ph.D

Professional members of NPF have free access to the journal through SAGE journals.

JPPA bases its policies on the guidelines set forth by the International Committee of Medical Journal Editors.

Earn AMA PRA Category 1 Credit(s)™ for selected articles.

JPPA is a member of the Committee on Publication Ethics (COPE).

JPPA is included in the ProQuest and Scopus abstracting and indexing databases

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2020 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.